Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial

References

• Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology. 2009;49(1):306–317. doi:10.1002/hep.22603
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917–923. doi:10.1053/jhep.2003.50161
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–2023. doi:10.1002/hep.25762
   PubMed Web of Science ®Google Scholar
• Lankarani KB, Ghaffarpasand F, Mahmoodi M, et al. Non alcoholic fatty liver disease in southern Iran: a population based study. Hepat Mon. 2013;13:5.
   Web of Science ®Google Scholar
• Day C, James O. Steatohepatitis: a tale of two” hits”. Gastroenterology. 1998;114:842–845. doi:10.1016/S0016-5085(98)70599-2
   PubMed Web of Science ®Google Scholar
• Shahmohammadi HA, Hosseini SA, Hajiani E, Malehi AS, Alipour M. Effects of green coffee bean extract supplementation on patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepat Mon. 2017;17(4):e12299. doi:10.5812/hepatmon.45609
   Web of Science ®Google Scholar
• Abbasnezhad A, Choghakhori R, Kashkooli S, Alipour M, Asbaghi O, Mohammadi R. Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2019 Des;34(12):2062–2070. doi:10.1111/jgh.14765
   Web of Science ®Google Scholar
• Mahdavinia M, Alizadeh S, Raesi Vanani A, et al. Effects of quercetin on bisphenol A-induced mitochondrial toxicity in rat liver. Iran J Basic Med Sci. 2019;22(5):499–505. doi:10.22038/ijbms.2019.32486.7952
   Web of Science ®Google Scholar
• Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008;46(2):409–420. doi:10.1016/j.fct.2007.09.085
   PubMed Web of Science ®Google Scholar
• Sahebkar A. Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. World J Gastroenterol. 2011;17(2):271. doi:10.3748/wjg.v17.i2.271
   PubMed Web of Science ®Google Scholar
• Verma S, Singh M, Jain P, Bordia A. Protective Effect of Ginger, Zingiber Officinale Rosc on Experimental Atherosclerosis in Rabbits. Indian J Exp Biol. 2004;42(7):736738.
   Google Scholar
• Jou J, Choi SS, Diehl AM, editors. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28(4):370–379. doi:10.1055/s-0028-1091981
   Google Scholar
• Mustafa T, Srivastava K, Jensen K. Drug development report. 9. Pharmacology of ginger, zingiber-officinale. J Drug Dev. 1993;6(1):25–39.
   Google Scholar
• Stoilova I, Krastanov A, Stoyanova A, Denev P, Gargova S. Antioxidant activity of a ginger extract (Zingiber officinale). Food Chem. 2007;102(3):764–770. doi:10.1016/j.foodchem.2006.06.023
   Web of Science ®Google Scholar
• Polyzos S, Kountouras J, Zavos C. The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease. Hippokratia. 2009;13(2):127.
   Web of Science ®Google Scholar
• Haukeland JW, Dahl TB, Yndestad A, et al. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol. 2012;166(3):503–510. doi:10.1530/EJE-11-0864
   Web of Science ®Google Scholar
• Gilani A, Ghayur M. Ginger: From Myths to Reality. Ethnotherapies in the Cycle of Life. BOD-Books on Demand/Ethnomed Institut Für Ethnomedizin eV: Munich; 2005:307–315.
   Google Scholar
• Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol. 2005;45(1):74–80. doi:10.1097/00005344-200501000-00013
   PubMed Web of Science ®Google Scholar
• Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1–10. doi:10.7326/0003-4819-137-1-200207020-00006
   PubMed Web of Science ®Google Scholar
• Khandouzi N, Shidfar F, Rajab A, Rahideh T, Hosseini P, Taheri MM. The effects of ginger on fasting blood sugar, hemoglobin a1c, apolipoprotein B, apolipoprotein aI and malondialdehyde in type 2 diabetic patients. Iran j Pharm Res. 2015;14(1):131.
   PubMed Web of Science ®Google Scholar
• Initiative NOE, Heart N, Lung, Institute B, Obesity NAAftSo, Identification EPot, et al. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The Institute; 2000.
   Google Scholar
• Ashtary-Larky D, Daneghian S, Alipour M, et al. Waist circumference to height ratio: better correlation with fat mass than other anthropometric indices during dietary weight loss in different rates. Int J Endocrinol Metab. 2018;16(4):e55023. doi:10.5812/ijem
   PubMed Web of Science ®Google Scholar
• Ebrahimzadeh Attari V, Malek Mahdavi A, Javadivala Z, Mahluji S, Zununi Vahed S, Ostadrahimi A. A systematic review of the anti-obesity and weight lowering effect of ginger (Zingiber officinale Roscoe) and its mechanisms of action. Phytother Res. 2017;32:577–585.
   Web of Science ®Google Scholar
• Atashak S, Peeri M, Azarbayjani MA, Stannard SR, Haghighi MM. Obesity-related cardiovascular risk factors after long-term resistance training and ginger supplementation. J Sports Sci Med. 2011;10(4):685.
   Web of Science ®Google Scholar
• Attari VE, Ostadrahimi A, Jafarabadi MA, Mehralizadeh S, Mahluji S. Changes of serum adipocytokines and body weight following Zingiber officinale supplementation in obese women: a RCT. Eur J Nutr. 2016;55(6):2129–2136. doi:10.1007/s00394-015-1027-6
   PubMed Web of Science ®Google Scholar
• Rahimlou M, Yari Z, Hekmatdoost A, Alavian SM, Keshavarz SA. Ginger supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Hepat Mon. 2016;16:1. doi:10.5812/hepatmon
   Web of Science ®Google Scholar
• Mozaffari-Khosravi H, Talaei B, Jalali B-A, Najarzadeh A, Mozayan MR. The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Complement Ther Med. 2014;22(1):9–16. doi:10.1016/j.ctim.2013.12.017
   PubMed Web of Science ®Google Scholar
• Nammi S, Sreemantula S, Roufogalis BD. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol. 2009;104(5):366–373. doi:10.1111/pto.2009.104.issue-5
   PubMed Web of Science ®Google Scholar
• Shanmugam KR, Mallikarjuna K, Kesireddy N, Reddy KS. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2011;49(4):893–897. doi:10.1016/j.fct.2010.12.013
   PubMed Web of Science ®Google Scholar
• Isa Y, Miyakawa Y, Yanagisawa M, et al. 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2008;373(3):429–434. doi:10.1016/j.bbrc.2008.06.046
   PubMed Web of Science ®Google Scholar
• Priya Rani M, Padmakumari K, Sankarikutty B, Lijo Cherian O, Nisha V, Raghu K. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Int J Food Sci Nutr. 2011;62(2):106–110. doi:10.3109/09637486.2010.515565
   PubMed Web of Science ®Google Scholar
• Li Y, Tran VH, Duke CC, Roufogalis BD. Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid Based Complement Alternat Med. 2012;2012:516870.
   Google Scholar
• Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. A Double Blind Controlled Clinical Trial. Saudi Med J. 2008;29(9):1280–1284.
   PubMed Web of Science ®Google Scholar
• ElRokh E-SM, Yassin NA, El-Shenawy SM, Ibrahim BM. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology. 2010;18(6):309–315. doi:10.1007/s10787-010-0053-5
   PubMedGoogle Scholar
• Bordia A, Verma S, Srivastava K. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukotrienes Essent Fatty Acids. 1997;56(5):379–384. doi:10.1016/S0952-3278(97)90587-1
   PubMed Web of Science ®Google Scholar
• Haukeland JW, Damås JK, Konopski Z, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44(6):1167–1174. doi:10.1016/j.jhep.2006.02.011
   PubMed Web of Science ®Google Scholar
• Belfort R, Harrison SA, Brown K, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 2006;355(22):2297–2307. doi:10.1056/NEJMoa060326
   PubMed Web of Science ®Google Scholar
• Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr. 2014;65(4):515–520. doi:10.3109/09637486.2014.880671
   PubMed Web of Science ®Google Scholar
• Atashak S, Azarbayjani M, Piri M, Jafari A. Effects of combination of long-term ginger consumption and resistance training on lipid peroxidation and insulin resistance in obese men. J Med Plants. 2012;2(42):179–188.
   Google Scholar
• Kim SO, Chun K-S, Kundu JK, Surh Y-J. Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-κB and p38 MAPK in mouse skin. Biofactors. 2004;21(1–4):27–31. doi:10.1002/biof.v21:1/4
   Web of Science ®Google Scholar
• Mathews ST, Singh GP, Ranalletta M, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 2002;51(8):2450–2458. doi:10.2337/diabetes.51.8.2450
   PubMed Web of Science ®Google Scholar
• Hennige AM, Staiger H, Wicke C, et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One. 2008;3(3):e1765. doi:10.1371/journal.pone.0001765
   PubMed Web of Science ®Google Scholar
• Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab. 2008;93(11):4479–4485. doi:10.1210/jc.2008-1505
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Yonal O, Kurt R, et al. Serum fetuin A/α 2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. Ann Clin Biochem. 2010;47(6):549–553. doi:10.1258/acb.2010.010169
   PubMed Web of Science ®Google Scholar
• Motawi TK, Hamed MA, Shabana MH, Hashem RM, Aboul Naser AF. Zingiber officinale acts as a nutraceutical agent against liver fibrosis. Nutr Metab. 2011;8:40.
   Google Scholar